Enter your login e-mail to the account
Search
Search parameters
Search results
- Effectiveness and safety of abiraterone acetate treatment for metastatic castration-resistant prostate cancer post-chemotherapy
MUDr. Tomáš Hradec, FEBU, MUDr. Otakar Čapoun, FEBU
(2/2018, Review articles ) - Increasing the accuracy of prostate cancer diagnostics by glycoprofiling of selected serum oncomarkers: clinical and economic impact per patient
Ing. Tomáš Bertók, PhD., MUDr. Roman Sokol, PhD., MPH, doc. MUDr. Juraj Fillo, CSc., Ing. Ján Tkáč, DrSc.
(4/2023, Review articles ) - Non-metastatic castration-resistant prostate cancer
MUDr. Jana Katolická, Ph.D.
(2/2022, Review articles ) - PARP inhibitors in treating metastatic castration-resistant prostate cancer
MUDr. Igor Richter, Ph.D., doc. MUDr. Josef Dvořák, Ph.D., MUDr. Vladimír Šámal, Ph.D., MUDr. Jiří Bartoš, MBA, MUDr. Sofya Al-Samsam
(3/2023, Review articles ) - Current treatment management of non-metastatic castration-resistant prostate cancer
MUDr. Nikol Rušarová, MUDr. Hana Študentová, Ph.D.
(1/2020, Review articles ) - Systemic radiotherapy for prostate cancer with bone metastases
MUDr. Otakar Čapoun, FEBU
(3/2016, Review articles ) - Treatment of non-metastatic castration-resistant prostate cancer
MUDr. Ivo Kocák, Ph.D.
(4/2020, Review articles ) - The role of ARTAs in treating metastatic castration-resistant prostate cancer
MUDr. PharmDr. Jan Dvořák
(2/2019, Review articles ) - Have we found an optimal sequence in the treatment of metastatic castrationally-resistant prostate cancer?
MUDr. Tomaš Svoboda, Ph.D.
(1/2019, Review articles )
- Overview of treatment of castration-resistant prostate cancer
MUDr. Jana Obertová
(4/2012, Review articles ) - The growth factors in oncology
MUDr. Ján Gyárfáš
(4/2012, Main topic ) - Biologic and targeted therapy for urogenital maliginities
MUDr. Mária Rečková
(1/2011, Review articles ) - Castration resistant prostate cancer in the year 2013
doc. MUDr. Jozef Marenčák, PhD.
(3/2013, Review articles ) - Radium 223Ra in the treatment of bone malignancies
prof. MUDr. Ján Kliment, CSc., MUDr. Hubert Poláček, Ph.D., doc. MUDr. Ivan Režňák, CSc.
(5/2016, Review articles ) - Proper selection of patients for Radium 223 and its role in metastatic castration-resistant prostate cancer treatment
JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M., MUDr. Ján Slopovský
(2/2021, Review articles ) - 18F-choline PET/CT in evaluation of therapeutic response of castration-resistant prostate cancer
Doc. MUDr. Soňa Balogová, PhD., MUDr. Lucia Noskovičová, MUDr. Lucia Kaliská FEBMN , MUDr. Marika Vereb, FEBMN, MUDr. Marek Bartovic
(3/2015, Review articles ) - Treatment of bone metastases in castration resistant prostate cancer – current view
doc. MUDr. Jozef Marenčák, PhD.
(3/2015, Review articles ) - Non-metastatic castration-resistant prostate cancer
JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M., MUDr. Ján Slopovský
(3/2019, Review articles ) - Lutetium-177-PSMA in therapy of metastatic prostate cancer
MUDr. Eva Takácsová, PhD.
(4/2022, Main topic ) - Immunotherapy and targeted treatment for metastatic, castration-resistant prostate cancer
MUDr. Ján Slopovský, JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(4/2022, Main topic ) - Review on castrate-resistant prostate carcinoma systemic therapy
Doc. JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(4/2023, Main topic ) - Current possibilities and view of treatment of castration refractory metastatic prostate cancer
MUDr. Radovan Barilla, PhD.
(5/2019, Main topic ) - Castration resistant prostate cancer – something new in the year 2014?
doc. MUDr. Jozef Marenčák, PhD.
(4/2014, Main topic ) - Správy z podujatia ASCO Chicago 2014
prof. MUDr. Stanislav Špánik, CSc., MUDr. Mária Rečková, MUDr. Patrik Palacka, PhD. MPH, MBA
(4/2014, Events ) - Nežiaduce účinky imunoterapie a ich manažment
MUDr. Jaroslava Lešková
(2/2018, Main topic ) - Death following brain metastases evolvement in patient with metastatic castration resistant adenocarcinoma of prostate treated by enzalutamide with low level PSA
MUDr. Roman Tomaškin, PhD.
(S1/2019, Case reports ) - Treatment of metastatic castrate-resistant prostate cancer with enzalutamide
MUDr. Klaudia Gočárová, PhD.
(S1/2019, Case reports ) - Favourable therapeutic response of enzalutamide in patient with metastatic castration resistant prostate cancer
MUDr. Martin Romančík, PhD., MPH
(S1/2019, Case reports ) - Enzalutamide in the treatment of metastatic castration-resistant prostate cancer
MUDr. Andrej Rosík, MUDr. Ladislav Slobodník
(S1/2019, Case reports ) - Enzalutamide in treatment of the metastatic castration resistant prostate cancer
Doc. MUDr. Jozef Marenčák, PhD.
(6/2017, Drugs & drug classes ) - New possibilities and view for treatment of castration resistent prostate cancer
doc. MUDr. Igor Andrašina, CSc., MUDr. Radovan Barilla, PhD.
(1/2012, Review articles ) - Therapy of castration-resistant prostate cancer from the point of view of nuclear medicine
MUDr. Eva Takácsová, PhD., Mgr. Žaneta Kantová
(1/2024, Review articles ) - Metastatic prostate cancer - new therapeutical approaches
MUDr. Patrik Palacka, PhD., MPH, MBA, Mgr. Soňa Herudová
(2/2015, Review articles ) - Novinky z American Society of Clinical Oncology 2010
doc. MUDr. Peter Beržinec, CSc., MUDr. Tomáš Šálek, prof. MUDr. Stanislav Špánik, CSc., MUDr. Mária Rečková
(4/2010, Events ) - Abiraterone in treatment of metastatic castrate resistant prostate cancer
prof. MUDr. Ján Kliment, CSc.
(2/2014, Drugs & drug classes ) - Management of sequential and combined treatment of a patient with metastatic prostate cancer
Doc. MUDr. Ján Breza, PhD.
(S1/2020, Case reports ) - Treatment of enzalutamide in the therapy of metastatic castration-resistant prostate cancer in postchemoindication
MUDr. Alexandra Szabová
(S1/2020, Case reports ) - Treatment of patient with metastatic prostate cancer – from sensitive to castration resistant disease – case report
MUDr. Vladimír Lenko, PhD., FEBU
(S1/2020, Case reports ) - Management of PSA progression after topical treatment of prostate cancer
doc. MUDr. Pavol Dubinský, PhD., MHA
(S1/2020, Case reports ) - Glukokortikoidy v liečbe kastračne-rezistentného karcinómu prostaty a mechanizmy rezistencie na androgénnu blokádu
JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(4/2018, Review articles )